KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $3.3 billion.

  • Biogen's Total Current Liabilities fell 3941.9% to $3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year decrease of 3941.9%. This contributed to the annual value of $3.3 billion for FY2025, which is 3941.9% down from last year.
  • Biogen's Total Current Liabilities amounted to $3.3 billion in Q4 2025, which was down 3941.9% from $3.3 billion recorded in Q3 2025.
  • Biogen's 5-year Total Current Liabilities high stood at $5.5 billion for Q4 2024, and its period low was $3.0 billion during Q1 2023.
  • Its 5-year average for Total Current Liabilities is $3.9 billion, with a median of $3.4 billion in 2023.
  • Over the last 5 years, Biogen's Total Current Liabilities had its largest YoY gain of 6437.26% in 2025, and its largest YoY loss of 3941.9% in 2025.
  • Quarter analysis of 5 years shows Biogen's Total Current Liabilities stood at $4.3 billion in 2021, then decreased by 23.86% to $3.3 billion in 2022, then grew by 4.93% to $3.4 billion in 2023, then skyrocketed by 60.99% to $5.5 billion in 2024, then tumbled by 39.42% to $3.3 billion in 2025.
  • Its Total Current Liabilities stands at $3.3 billion for Q4 2025, versus $3.3 billion for Q3 2025 and $3.2 billion for Q2 2025.